The invention is directed to novel quinazoline and quinazoline-like derivatives of Formula (I): ##STR00001## useful as integrin antagonists and methods for the treatment of integrin-mediated disorders.

 
Web www.patentalert.com

< Organic compounds with biological activity as thrombin inhibitors and use thereof

< Benzyllactobionamides as inhibitors of smooth muscle cell proliferation

> Imidazo-substituted compounds as p38 kinase inhibitors

> Antibodies to serine protease polypeptides
~ 00276